Use of Neurofeedback to Enhance Attention After Brain Injury
NCT ID: NCT03324178
Last Updated: 2019-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2018-02-02
2018-07-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Neurofeedback (NFB) allows the self-regulation of brain activity using visual feedback. Very recently, it has been demonstrated that NFB training targeted at reducing alpha power (alpha desynchronization NFB), can induce initial plastic changes in brain networks associated with attention. It has been proposed that NFB can improve cognitive performance by tuning oscillatory activity of the brain towards a more healthy balance between neural network flexibility and stability. It is speculated that the use of alpha desynchronization NFB training, with people who present with brain injury, can enhance sustained attention in as much as the training promotes neural variability during resting state (i.e. more flexible network configuration) and neural stability during a sustained attention task (i.e. more stable network configuration).
However, before assessing the effectiveness of the intervention, it is necessary to evaluate the feasibility and acceptability thereof. This study will recruit 14 participants and randomly assign them to two groups: a NFB group and a video games control group. Long-term changes will be evaluated at two time points for both groups: baseline and post-intervention. The NFB group will have a follow-up session one week after the intervention, to evaluate whether there are long lasting changes after NFB training. In addition, short-term changes of NFB will be evaluated for the experimental group, contrasting EEG activity immediately before and after the last NFB session.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Neurofeedback Training on Attentional Deficits in Patients With Acquired Brain Injury
NCT06863025
The Effect of Mindfulness on Cognition and Emotion Following Acquired Brain Injury
NCT03231488
Training in Goal-directed Attention Regulation for Individuals With Brain Injury
NCT01035606
Computerized Attention Training for Individuals With Acquired Brain Injury
NCT01641432
Brain Markers of Improvements in Cognitive Functioning
NCT03490110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each participant will be involved in the study for a maximum of 5 weeks. The NFB training and control sessions for all participants are expected to be completed over the course of five months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neurofeedback training
Sixteen 30-minute sessions of neurofeedback training performed once a day over the course of four weeks (four sessions each week)
Neurofeedback training
Sixteen 30-minute sessions of neurofeedback training over four weeks: 7 x 3-minute blocks of training flanked by a 3-minute resting state block with eyes-open.
Video game control group
Sixteen 30-minute sessions of playing video games once a day over the course of four weeks (four sessions each week)
Video game
Sixteen 30-minute sessions of video game playing over four weeks: 7 x 3-minute blocks flanked by a 3-minute seated relaxation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurofeedback training
Sixteen 30-minute sessions of neurofeedback training over four weeks: 7 x 3-minute blocks of training flanked by a 3-minute resting state block with eyes-open.
Video game
Sixteen 30-minute sessions of video game playing over four weeks: 7 x 3-minute blocks flanked by a 3-minute seated relaxation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to provide consent
* non-progressive brain injury
* impairment of sustained attention
* stable medication regime (expected not to change during the period of the study)
* minimum computer literacy (owning a computer, laptop, tablet, ipad etc)
* native English-speakers
Exclusion Criteria
* co-morbid progressive neurological or neurodegenerative condition
* aggressive behaviour
* unhealed scalp wounds
* unable to give informed consent
* unable to cooperate with the study protocol (e.g. severe aphasia, uncorrected impairment of hearing or vision, illiteracy or unable to understand English)
* clinically unstable (e.g. due to major intercurrent illness)
* undertaking changes in the existing treatment
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brain Injury Rehabilitation Trust
OTHER
University of Glasgow
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Jon Evans
Professor of Applied Neuropsychology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jon Evans, PhD
Role: STUDY_DIRECTOR
Professor of Applied Neuropsychology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brain Injury Rehabilitation Trust
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-WS-0211
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.